Johnson, L. E., Brockstedt, D., Leong, M., Lauer, P., Theisen, E., Sauer, J., & McNeel, D. G. (2018). Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming. Oncoimmunology.

Johnson, Laura E., Dirk Brockstedt, Meredith Leong, Peter Lauer, Erin Theisen, John-Demian Sauer, und Douglas G. McNeel. "Heterologous Vaccination Targeting Prostatic Acid Phosphatase (PAP) Using DNA and Listeria Vaccines Elicits Superior Anti-tumor Immunity Dependent On CD4+ T Cells Elicited By DNA Priming." Oncoimmunology 2018.

Johnson, Laura E., et al. "Heterologous Vaccination Targeting Prostatic Acid Phosphatase (PAP) Using DNA and Listeria Vaccines Elicits Superior Anti-tumor Immunity Dependent On CD4+ T Cells Elicited By DNA Priming." Oncoimmunology 2018.